Accounts Receivable, Net

9 Months Ended

Sep. 30, 2013

Accounts Receivable, Net

Accounts Receivable, Net

D. Accounts Receivable, Net

Our net accounts receivable were $8.8 million and $6.4 million as of September 30, 2013 and December 31, 2012, respectively, and primarily represented amounts due from wholesalers and distributors to whom we sell Feraheme directly. Accounts receivable are recorded net of reserves for estimated chargeback obligations, prompt payment discounts and any allowance for doubtful accounts. Reserves for other sales-related allowances such as rebates, distribution and other fees, and product returns are included in accrued expenses in our condensed consolidated balance sheets.

Customers which represented greater than 10% of our accounts receivable balances as of September 30, 2013 and December 31, 2012 were as follows:

	September 30, 2013		December 31, 2012
AmerisourceBergen Drug Corporation	48	%	48	%
Cardinal Health, Inc.	28	%	18	%
McKesson Corporation	19	%	28	%